2017, Number 4
<< Back Next >>
Aten Fam 2017; 24 (4)
Gaucher disease: a case study
Lucio-García C, Noriega-Salas L
Language: Spanish
References: 10
Page: 176-178
PDF size: 149.22 Kb.
ABSTRACT
Gaucher disease (GD) is an autosomal recessive hereditary disorder, which causes disturbances on target
organs such as liver, spleen, nervous system, bone marrow and lungs.
Case report: A five-year-old male
patient with persistent episodes of epistaxis with two weeks of progression, limb ecchymosis and hepatosplenomegaly,
pain in the limbs, progressive loss of muscle strength, psychomotor regression during
10 months, and myoclonic epilepsy. The X-ray from long bones showed the shape of an Erlenmeyer
flask, bone marrow biopsy with hypercellularity, due to abundant foamy histiocytes and lysosomal
accumulation. We integrated the diagnosis and stratification of eg type iii b.
Conclusion: enzyme
replacement therapy imiglucerase, topiramate, calcitriol and calcium carbonate improved the clinical
condition of the patient.
REFERENCES
Beutler E, Nguyen NJ, Henneberger MW, et al. Gaucher disease: gene frequencies in the Ashkenazi Jewish population. Am J Hum Genet. 1993;52:85-8.
Franco S. Consenso Mexicano de Enfermedad de Gaucher. Rev Med Inst Mex Seguro Soc. 2010;48(2):167-86.
Meikle PJ, Fuller M, Hopwood JJ. Epidemiology and screening policy. En: Futerman AH, Zimran A, editores. Gaucher disease. Boca Raton: Taylor and Francis Group; 2007. 321e40.
Guggenbuhl P, et al. Gaucher disease. Joint Bone Spine. 2008;75:116-24.
Grabowski G. Phenotype, diagnosis and treatment of Gracher’s disease. Lancet. 2008;372:1263-71.
Mikosch P. Gaucher disease and bone. Best Practice & Research Clinical Rheumatology. 2011;25:665-81.
Harmanci O. Gaucher disease: New developments in treatment and etiology. World J Gastroenterol. 2008;14(25):3968-73.
Faden, et al. The Erlenmeyer Flask Bone Deformity in the Skeletal Dysplasias. Am J Med Genet A. 2009;149(6):1334-45.
Nagral. Gaucher Disease. Journal of Clinical and Experimental Hepatology.
Drelichman G. Clinical Consequences of Interrumpting Enzyme Replacement Therapy in Children with type 1 Gaucher Disease. J Pediatr. 2007;151:197-201.